Development of novel targeted therapies in the treatment of malignant glioma

Nat Rev Drug Discov. 2004 May;3(5):430-46. doi: 10.1038/nrd1380.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Antibiotics, Antineoplastic / adverse effects
  • Antibiotics, Antineoplastic / therapeutic use*
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / mortality
  • Brain Neoplasms / physiopathology
  • Cell Cycle / genetics*
  • Cell Cycle / physiology
  • Clinical Trials as Topic
  • Epidermal Growth Factor / antagonists & inhibitors
  • Glioma / drug therapy*
  • Glioma / mortality
  • Glioma / physiopathology
  • Humans
  • Middle Aged
  • Molecular Biology*
  • Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors
  • Tumor Suppressor Protein p53 / genetics*
  • Tumor Suppressor Protein p53 / physiology

Substances

  • Antibiotics, Antineoplastic
  • Tumor Suppressor Protein p53
  • Epidermal Growth Factor
  • Receptors, Vascular Endothelial Growth Factor